insights_auto
Waarom is 2359 gedaald 2,19%?
Meer informatiechevron_right
2359:HKG
WuXi AppTec Ord Shs H
HK$Â 196,20
arrow_downward
-2,19%(-4,40) 1D
16 okt, 16:08:14 GMT+8 · HKD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor 2359 genereren…
Openen
HK$Â 203,80
Hoog
HK$Â 209,00
Laag
HK$Â 185,00
Beursw.
544,52Â mld.
Gem. vol.
3,91Â mln.
Volume
10,16Â mln.
Dividend
1,22%
Kwartaaldividend
HK$Â 0,60
Ex-dividenddatum
4 sep 2026
Koers/winst-verhouding
23,98
52 wk hoog
HK$Â 219,20
52 wk laag
HK$Â 96,70
WPA
HK$Â 8,18
Aantal medewerkers
36K
Openen
HK$Â 203,80
Hoog
HK$Â 209,00
Laag
HK$Â 185,00
Beursw.
544,52Â mld.
Gem. vol.
3,91Â mln.
Volume
10,16Â mln.
Dividend
1,22%
Kwartaaldividend
HK$Â 0,60
Ex-dividenddatum
4 sep 2026
Koers/winst-verhouding
23,98
52 wk hoog
HK$Â 219,20
52 wk laag
HK$Â 96,70
WPA
HK$Â 8,18
Aantal medewerkers
36K
Nieuwsartikelen
Van webbronnen en nieuwspartners
ad-hoc-news.de
·
1 uur geleden
WuXi AppTec earns EcoVadis gold: what it means for WuXi AppTec stock
Profiel
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
Over WuXi AppTec Ord Shs H
CEOSteve Yang | Ge Li
Medewerkers35,6K
Opgericht1 dec 2000
Hoofdkantoor-
Sector-
Websitewuxiapptec.com.cn